Back
Enliven Therapeutics Stock Price Chart
Buy
66
ELVN
Enliven Therapeutics
Last Price:
23.81
Seasonality Move:
-10.25%
7 Day Trial
ALL ACCESS PASS
$
7
- The current trend is moderately bullish and ELVN is experiencing slight selling pressure.
Enliven Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.97 | Buy |
| 20-day SMA: | 20.5 | Buy |
| 50-day SMA: | 18.56 | Buy |
| 200-day SMA: | 15.31 | Buy |
| 8-day EMA: | 23.37 | Buy |
| 20-day EMA: | 21.58 | Buy |
| 50-day EMA: | 19.36 | Buy |
| 200-day EMA: | 16.61 | Buy |
Enliven Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.7 | Buy |
| Relative Strength Index (14 RSI): | 64.48 | Buy |
| Chaikin Money Flow: | -122745 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.46 - 23.42) | Buy |
| Bollinger Bands (100): | (13.68 - 20) | Buy |
Enliven Therapeutics Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Enliven Therapeutics Stock
Is Enliven Therapeutics Stock a Buy?
- Enliven Therapeutics share price is 24.00 while ELVN 8-day simple moving average is 23.97, which is a Buy signal.
- The stock price of ELVN is 24.00 while Enliven Therapeutics 20-day SMA is 20.50, which makes it a Buy.
- Enliven Therapeutics 50-day simple moving average is 18.56 while ELVN share price is 24.00, making it a Buy technically.
- ELVN stock price is 24.00 and Enliven Therapeutics 200-day simple moving average is 15.31, creating a Buy signal.
ELVN Technical Analysis vs Fundamental Analysis
Buy
66
Enliven Therapeutics (ELVN)
is a Buy
Is Enliven Therapeutics a Buy or a Sell?
-
Enliven Therapeutics stock is rated a Buy
The current Enliven Therapeutics [ELVN] share price is $24.00. The Score for ELVN is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
Enliven Therapeutics Stock Info
Market Cap:
1.13B
Price in USD:
24.00
Share Volume:
395.85K
Enliven Therapeutics 52-Week Range
52-Week High:
26.00
52-Week Low:
9.80
Buy
66
Enliven Therapeutics (ELVN)
is a Buy
Enliven Therapeutics Share Price Forecast
-
What is the Enliven Therapeutics stock price today?
The Enliven Therapeutics stock price is 24.00 USD today. -
Will ELVN stock go up or go down?
Enliven Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Enliven Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Enliven Therapeutics is not overvalued.
Is Enliven Therapeutics Stock a Buy?
- Enliven Therapeutics share price is 24.00 while ELVN 8-day exponential moving average is 23.37, which is a Buy signal.
- The stock price of ELVN is 24.00 while Enliven Therapeutics 20-day EMA is 21.58, which makes it a Buy.
- Enliven Therapeutics 50-day exponential moving average is 19.36 while ELVN share price is 24.00, making it a Buy technically.
- ELVN stock price is 24.00 and Enliven Therapeutics 200-day simple moving average is 16.61, creating a Buy signal.
Fundamental Analysis of Enliven Therapeutics
Is Enliven Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Enliven Therapeutics
Should I short Enliven Therapeutics stock?
- ELVN Moving Average Covergence Divergence (MACD) indicator is 1.7, suggesting Enliven Therapeutics is a Buy
- Enliven Therapeutics Relative Strength Index (RSI) is 64.48, which suggest Enliven Therapeutics is overbought
- The Bollinger Bands (25) for Enliven Therapeutics is (17.46 - 23.42), which suggest Enliven Therapeutics is a Buy
- The Bollinger Bands (100) for Enliven Therapeutics is (13.68 - 20), which suggest Enliven Therapeutics is a Buy
* Enliven Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.